"Niflugel"@en . . . . . . . . . "approved"@en . "Niflumic acid is able to inhibit both phospholipase A2 as well as COX-2, thereby acting as an antiinflamatory and pain reduction agent."@en . "# Criddle DN, de Moura RS, Greenwood IA, Large WA: Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 1997 Mar;120(5):813-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9138686"@en . "Humans and other mammals"@en . "Acide niflumique"@en . "Used in the treatment of rheumatoid arthritis."@en . . . "Niflumic Acid"@en . "Acido niflumico"@en . "90% bound to plasma proteins."@en . . . . "Well absorbed following oral administration."@en . . . . . . . . . . . "Oral, mouse: LD₅₀ = 350 mg/kg; Oral, rat: LD₅₀ = 250 mg/kg"@en . "4394-00-7"@en . . "NFA"@en . "Acidum niflumicum"@en . . . . . . "2.5 hours"@en . . . . " "@en . . . . . . . . . . "An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. [PubChem]"@en . . . .